Cochlear | COH - Umsatzkosten

Aktienkurs
91.99
Täglich Wechseln
1.99 2.21%
Monatlich
-45.60%
Jährlich
-66.38%
Q2 Prognose
95.52




Umsatzkosten Veränderung Datum
Ansell USD 605.3M 351.2M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Fisher Paykel Healthcare NZD 402.8M 15.2M 2025-12
Healius AUD 218.7M 110.8M 2025-06
Integral Diagnostics AUD 11.53M 146K 2024-06
Mayne Pharma AUD 43.74M 2.67M 2024-06
Mesoblast USD -7.6M 27.47M 2025-12
Monash IVF AUD 27.42M 17.08M 2025-12
Nanosonics AUD 24.22M 1.11M 2025-12
Polynovo AUD 9.02M 3.51M 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 536.28M 21.52M 2025-12
Sigma Healthcare AUD 1.55B 165.16M 2024-12
Somnomed AUD 16.9M 2.11M 2023-06
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Telix Pharmaceuticals AUD 221.36M 20.78M 2025-12